Tumor markers kinetic in malignant lung neoplasms

Journal of Cardiovascular Surgery

Volumn 40, Issue 2, 1999, Pages 299-305

  Cristofori, R ^a   Aimo, G ^c   Mengozzi, G ^c   Oliaro, A ^a,b   Revello, F ^c   Rapellino, M ^c  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c NONE

Author keywords

Lung neoplasms; Postoperative period; Prognosis; Tumor markers, biological

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; NEURON SPECIFIC ENOLASE; TISSUE POLYPEPTIDE ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HALF LIFE TIME; HUMAN; IMMUNORADIOMETRIC ASSAY; LUNG CARCINOMA; MALE; PROGNOSIS;

AGED; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, BRONCHOGENIC; FEMALE; HALF-LIFE; HUMANS; KERATINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROGNOSIS; TIME FACTORS; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0032935541     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Gion M, Mione R, Barcoli P, Dittadi R. Dynamic use of tumor markers: rational-clinical application and pitfalls. Anticancer Res 1996;16(4B):2279-84.
2. Weissbach L, Bussar Maatz R, Mann K. The value of tumor markers in testicular seminomas. Results of a prospective study. Eur Urol 1997;32(1):16-22.
3. Niklinski J, Furman M, Landavski J, Kolowski M. Prognostic value of pretreatment CEA, SCC-Ag and CA 19-9 levels in sera of patients with non-small cell lung cancer. Eur J Cancer Prev 1992;1:401-6.
4. Buccheri GF, Ferrigno D. Prognostic value of tissue polypeptide antigen in lung cancer. Chest 1992;101:1287-92.
5. Verhelst J, Vanden Broecke E, Van Meerbeeck J, De Backer W, Blockx P, Vermeire P. Calculation of half-life of carcinoembryonic antigen after lung tumor resection: a case report. Eur Respir J 1991;4:374-6.
6. Pecchio F, Rapellino M, Ruffini E, Cavallo A. Half-life of carcinoembryonic antigen following curative resection of adenocarcinoma of the lung. Int J Biol Markers 1992;7(2):119-20.
7. Rapellino M, Piantino P, Pecchio F, Ruffini E, Cavallo A, Scappaticci E et al. Disappearance curves of tumor marker after curative resection. Int J Biol Markers 1994;9:33-37.
8. Buccheri GF, Ferrigno D, Vola F. Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancer. Lung Cancer 1993;10:21-33.
9. Rapellino M, Pecchio F, Baldi S, Scappaticci E, Cavallo A. Clinical utility of tissue polypeptide antigen in lung cancer management. Anticancer Res 1995;15(3):1065-70.